Your browser doesn't support javascript.
loading
Peri-Neural Invasion Is an Important Prognostic Factor of T2N0 Oral Cancer.
Cheng, Chi-Sheng; Chen, Chien-Chih; Liu, Yi-Chun; Wang, Chen-Chi; Chou, Yu-Shu.
Afiliación
  • Cheng CS; Department of Oral and Maxillofacial Surgery, Taichung Veterans General Hospital, Taichung 407219, Taiwan, China.
  • Chen CC; Department of Radiation Oncology, Taichung Veterans General Hospital, Taichung 407219, Taiwan, China.
  • Liu YC; Department of Medical Imaging and Radiological Sciences, Central Taiwan University of Science and Technology, Taichung 406053, Taiwan, China.
  • Wang CC; Department of Radiation Oncology, Taichung Veterans General Hospital, Taichung 407219, Taiwan, China.
  • Chou YS; Institute of Clinical Medicine, National Yang Ming University, Taipei 407219, Taiwan, China.
Medicina (Kaunas) ; 58(12)2022 Dec 08.
Article en En | MEDLINE | ID: mdl-36557011
ABSTRACT
Background and

objectives:

Among patients with pathologically proven T2N0 oral squamous cell carcinoma (OSCC), a notable amount of patients still die from tumor recurrence although they have radical surgery for early stage cancers. In literature, the prognostic indicators of this specific disease entity were rarely reported. This study aims at analyzing the prognostic factors of T2N0 OSCC patients and discussing possible managements to improve the survival. MATERIALS AND

METHODS:

From January 2012 to December 2017, the data of 166 pathologically proven T2N0 oral cancer patients proved by radical surgery were retrospectively collected. The clinical and pathologic factors including age, gender, tumor differentiation grade, perineural invasion (PNI), angiolymphatic invasion (ALI), margin status, and adjuvant therapy were analyzed by univariate and multivariate analysis to determine their association with disease-specific survival (DSS), and disease-free survival (DFS), which were calculated by Kaplan-Meier method.

RESULTS:

After median follow up time of 43.5 months, overall 3-year rates of DSS and DFS were 86.1% and 80.1% respectively for our 166 patients. Univariate analysis showed that the 3-year DSS of 90.8% for PNI negative patients was significantly better than DSS of 57.0% for PNI positive patients (p = 0.0006). The 3-year DFS of 84.2% for PNI negative patients was also significantly better than DFS of 54.6% for PNI positive patients (p = 0.001). Further multivariate analysis revealed PNI was the only independent prognostic factor associated with both DSS (Hazard Ratio (HR) = 5.02; 95% Confidence Interval (CI) = 1.99-12.6; p = 0.001), and DFS (HR = 3.92; 95% CI = 1.65-9.32; p = 0.002). Nearly 10% (16) of the 166 patients had adverse pathologic feature of PNI only. In the 11 patients without adjuvant therapy, 5 patients died from OSCC. No patients had recurrence or mortality after they received adjuvant therapy with chemotherapy ± radiotherapy.

CONCLUSION:

PNI was an independent prognostic factor for T2N0 oral cancer patients. Adjuvant chemotherapy and radiotherapy may benefit the survival of this specific disease entity, but further investigations are needed to elucidate the optimal regimen.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Boca / Carcinoma de Células Escamosas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Medicina (Kaunas) Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Boca / Carcinoma de Células Escamosas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Medicina (Kaunas) Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: China